Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression

Psychopharmacology

Volumn 178, Issue 1, 2005, Pages 58-66

  Hegerl, Ulrich ^a   Mergl, Roland ^a   Henkel, Verena ^a   Pogarell, Oliver ^a   Müller Siecheneder, Florian ^a   Frodl, Thomas ^a   Juckel, Georg ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Citalopram; Depression; Digitizing graphic tablet; Hand motor function; Kinematical analysis; Reboxetine

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; HYPNOTIC AGENT; IMIDAZOPYRIDINE DERIVATIVE; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; PIPAMPERONE; PROMETHAZINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; ZOLPIDEM; ZOPICLONE;

ADULT; ARTICLE; AUTOMATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIGITALIZATION; DRUG EFFECT; DRUG SELECTIVITY; FEMALE; HAND FUNCTION; HAND MOVEMENT; HANDWRITING; HUMAN; KINEMATICS; MAJOR DEPRESSION; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOVEMENT (PHYSIOLOGY); OPEN STUDY; PRIORITY JOURNAL; SCORING SYSTEM; TASK PERFORMANCE; VELOCITY;

ACUTE DISEASE; ADRENERGIC UPTAKE INHIBITORS; ADULT; BIOMECHANICS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HAND; HANDWRITING; HUMANS; MALE; MORPHOLINES; MOVEMENT; PSYCHOMOTOR PERFORMANCE; SEROTONIN UPTAKE INHIBITORS;

EID: 14544273732     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1983-7     Document Type: Article

References (37)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington D.C.
2. Box GEP (1954) Some theorems on quadratic forms applied in the study of analysis of variance problems. II. Effects of inequality of variance and of correlation between errors in the two-way classification. Ann Math Stat 25:484-498
3. Caligiuri MP, Ellwanger J (2000) Motor and cognitive aspects of motor retardation in depression. J Affect Disord 57:83-93
4. Cummings JL (1992) Depression and Parkinson's disease: a review. Am J Psychiatry 149:443-454
5. Dilling H, Mombour W, Schmidt MH (1992) World Health Organization: ICD-10 Kapitel V (F). Internationale Klassifikation psychischer Störungen. Huber, Göttingen
6. Ferguson JM, Mendels J, Schwärt GE (2002) Effects of reboxetine on Hamilton depression rating scale factors from randomized, placebo-controlled trials in major depression. Int Clin Psychopharmacol 17:45-51
7. Fleminger S (1992) Control of simultaneous movements distinguishes depressive motor retardation from Parkinson's disease and neuroleptic parkinsonism. Brain 115:1459-1480
8. Gony M, Lapeyre-Mestre M, Montastruc JL, French Network of Regional Pharmacovigilance Centers (2003) Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs. Clin Neuropharmacol 26:142-145
9. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
10. Henkel V, Mergl R, Juckel G, Rujescu D, Mavrogiorgou P, Giegling I, Möller H-J, Hegerl U (2001) Assessment of handedness using a digitizing tablet: a new method. Neuropsychologia 39:1158-1166
11. Hindmarch I (1997) The effects of antidepressants on psychomotor function with particular reference to reboxetine. Eur Neuropsychopharmacol 7(Suppl 1):S17-S21
12. Kerr JS, Powell J, Hindmarch I (1996) The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Pharmacol 42:239-241
13. Lader M, Melhuish A, Frcka G, Fredricson Overo K, Christensen V (1986) The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur J Clin Pharmacol 31:183-190
14. Lane RM (1998) SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol 12:192-214
15. Lemelin S, Baruch P (1998) Clinical psychomotor retardation and attention in depression. J Psychiatr Res 32:81-88
16. Lemke MR (2002) Effect of reboxetine on depression in Parkinson's disease patients. J Clin Psychiatry 63:300-304
17. Linazasoro G (2000) Worsening of Parkinson's disease by citalopram. Parkinsonism Relat Disord 6:111-113
18. Mai N, Marquardt C (1992) CS - Computerunterstützte Analyse der Bewegungsabläufe beim Schreiben. Bedienungshandbuch. MedCom, München
19. Marquardt C, Mai N (1994) A computational procedure for movement analysis in handwriting. J Neurosci Methods 52:39-45
20. Mergl R, Tigges P, Schröter A, Möller H-J, Hegerl U (1999) Digitized analysis of handwriting and drawing movements in healthy subjects: methods, results and perspectives. J Neurosci Methods 90:157-169
21. Mergl R, Juckel G, Rihl J, Karner M, Tigges P, Schröter A, Hegerl U (2004) Kinematical analysis of handwriting movements in depressed patients. Acta Psychiatr Scand 109:383-391
22. Meulenbroek RGJ, van Galen GP (1988) The acquisition of skilled handwriting: discontinuous trends in kinematic variables. In: Colley A, Beech J (eds) Cognition and action in skilled behaviour. Elsevier, Amsterdam, pp 273-281
23. Milne JR, Goa KL (1991) Citalopram. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs 41:450-477
24. Muldoon C (1996) The safety and tolerability of citalopram. Int Clin Psychopharmacol 11(Suppl 1):35-40
25. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 9:97-113
26. Parkinson Study Group Richard ICH, Kurlan R (1997) A survey of antidepressant drug use in Parkinson's disease. Neurology 49:1168-1170
27. Sabbe B, van Hoof JJM, Hulstijn W, Zitman FG (1996) Changes in fine motor retardation in depressed patients treated with fluoxetine. J Affect Disord 40:149-157
28. Sabbe B, van Hoof JJM, Hulstijn W, Zitman FG (1997) Depressive retardation and treatment with fluoxetine: assessment of the motor component. J Affect Disord 43:53-62
29. Sabbe B, Hulstijn W, van Hoof JJM, Tuynman-Qua HG, Zitman F (1999) Retardation in depression: assessment by means of simple motor tasks. J Affect Disord 55:39-44
30. Sachdev P, Aniss AM (1994) Slowness of movement in melancholic depression. Biol Psychiatry 34:253-262
31. Siepmann M, Muck-Weymann M, Joraschky P, Kirch W (2001) The effects of reboxetine on autonomic and cognitive functions in healthy volunteers. Psychopharmacology 157:202-207
32. Thomassen AJWM, van Galen GP (1992) Handwriting as a motor task: experimentation, modelling, and simulation. In: Summers JJ (ed) Approaches to the study of motor control and learning. Elsevier, Amsterdam, pp 113-144
33. Tucha O, Aschenbrenner S, Eichhammer P, Putzhammer A, Sartor H, Klein HE, Lange KW (2002) The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression. Psychopharmacology 159:211-215
34. Tucker DM, Williamson PA (1984) Asymmetric neural control systems in human self-regulation. Psychol Rev 91:185-215
35. Volz H-P, Steil R, Kriese B, Kimmel M, Sauer H, Schüler P, Straube ER (2000) Effekte von Reboxetin und Paroxetin im Vergleich zu Placebo auf kognitive Prozesse bei Gesunden. Nervenarzt 71 (Suppl 1):S139
36. World Health Organization (WHO) (1992) International statistical classification of diseases and related health problems (ICD-10). Chapter V. Mental and behavioral disorders. Diagnostic guidelines. World Health Organization, Geneva
37. Yamato H, Kannari K, Shen H, Suda T, Matsunaga M (2001) Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum. Neuroreport 12:1123-1126